As far as we can ascertain, this is the first attempt to quantify the "clincal state" of the chelation treatment patient within the limits of a time-tested and respected measuring instrument, the Cornell Medical Index Health Questionnaire.  It can be safely concluded that the average patient is significantly ill and that, after approximately 26 infusions extending over about 60 days of therapy, the overall clinical symptomatology is reduced about 15 % and the system analysis shows an improvement from a low of 11 (in the gastrointestinal and urinary systems) to a high of 31 % (in the musculosketal system).   It is hoped that this report will catalyze more interest in pursuing the "clinical state" of the chelation treated patient.